These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12762303)

  • 1. Routine prostate screening may be unnecessary and harmful.
    Levenson D
    Rep Med Guidel Outcomes Res; 2003 Jan; 14(1):5-7. PubMed ID: 12762303
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical practice. Screening for prostate cancer.
    Hoffman RM
    N Engl J Med; 2011 Nov; 365(21):2013-9. PubMed ID: 22029754
    [No Abstract]   [Full Text] [Related]  

  • 3. Controversies in prostate cancer screening and treatment.
    Gaines KK
    Urol Nurs; 2010; 30(3):165-6. PubMed ID: 20648853
    [No Abstract]   [Full Text] [Related]  

  • 4. The efficacy of screening for carcinoma of the prostate by digital examination.
    Love RR
    Am J Prev Med; 1985; 1(6):36-46. PubMed ID: 3916716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study questions colorectal and prostate cancer screening priorities.
    Levenson D
    Rep Med Guidel Outcomes Res; 2003 Apr; 14(7):1-2, 5. PubMed ID: 12848147
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for prostate cancer: current recommendations.
    Wilson SS; Crawford ED
    Urol Clin North Am; 2004 May; 31(2):219-26. PubMed ID: 15123402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer: screening and treatment options.
    Horger DC; Clarke HS
    J S C Med Assoc; 2003 Apr; 99(4):85-7. PubMed ID: 12762154
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate cancer as a public health issue in North Carolina.
    Stark N; Paskett E; Demark-Wahnefried W; Carbone E; Godley P
    N C Med J; 2001; 62(5):286-90. PubMed ID: 11570328
    [No Abstract]   [Full Text] [Related]  

  • 9. Counseling patients about prostate cancer screening.
    Foxhall LE; Von Eschenbach AC
    Am Fam Physician; 2002 May; 65(9):1752, 1754, 1757. PubMed ID: 12018801
    [No Abstract]   [Full Text] [Related]  

  • 10. What is the difference between screening and diagnostic tests?
    Johns Hopkins Med Lett Health After 50; 2002 Jul; 14(5):8. PubMed ID: 12154802
    [No Abstract]   [Full Text] [Related]  

  • 11. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
    Barry MJ; Mulley AJ
    J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
    Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSA-based screening for localised prostate cancer. Uncertain benefits, potential adverse consequences, and many outstanding questions.
    Prescrire Int; 2009 Oct; 18(103):225. PubMed ID: 19882799
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum prostate-specific antigen screening for prostate cancer: application of current evidence to model criteria.
    Patel SH
    Appl Health Econ Health Policy; 2003; 2(2):79-83. PubMed ID: 14619278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME
    Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer. Examining the risks and benefits of screening.
    Cotter VT
    Adv Nurse Pract; 1998 Jul; 6(7):51-3. PubMed ID: 9782799
    [No Abstract]   [Full Text] [Related]  

  • 17. Testing for prostate cancer. A consumer view.
    Gardner M
    Aust Fam Physician; 2003 Jun; 32(6):398-9. PubMed ID: 12833762
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality. A case-control study.
    Walsh PC
    J Urol; 2005 Nov; 174(5):1824-5. PubMed ID: 16217296
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection and selection decisions in the practice of screening mammography.
    Stewart TR; Mumpower JL
    J Policy Anal Manage; 2004 Aug; 23(4):908-20. PubMed ID: 15505941
    [No Abstract]   [Full Text] [Related]  

  • 20. Move forward with prostate Ca education despite lack of consensus over screening.
    Healthc Demand Dis Manag; 1998 Jun; 4(6):93-4. PubMed ID: 10180833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.